KZA 0.00% 8.0¢ kazia therapeutics limited

KAZIA ENTERS CLINICAL COLLABORATION WITH CORNELL UNIVERSITY FOR...

  1. 375 Posts.
    lightbulb Created with Sketch. 120
    KAZIA ENTERS CLINICAL COLLABORATION WITH CORNELL UNIVERSITY FOR PHASE II CLINICAL STUDY USING PAXALISIB IN COMBINATION WITH KETOGENIC DIET FOR GLIOBLASTOMA

 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.